In this regard, it was previously shown that TGF-β-responsive tumor-initiating cells become resistant to adoptive cytotoxic T cell transfer (ACT) immunotherapy by inducing the expression of CD80 in a mouse cSCC model76. The gene discussed is CD80; the disease is neoplasm.